StonvexLoading…
StonvexCore line items from COST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-02-15 | Q4 2025 2025-11-23 | Annual 2025 2025-08-31 | Q2 2025 2025-05-11 |
|---|---|---|---|---|
Revenue | $136.90B | $67.31B | $275.24B | $189.08B |
Operating Income | $5.07B | $2.46B | $10.38B | $7.04B |
Net Income | $4.04B | $2.00B | $8.10B | $5.49B |
EPS (Diluted) | $9.08 | $4.50 | $18.21 | $12.34 |
Total Assets | $83.64B | $82.79B | $77.10B | $75.48B |
Total Liabilities | $51.55B | $52.49B | $47.94B | $48.36B |
Cash & Equivalents | $17.38B | $16.22B | $14.16B | $13.84B |
Free Cash Flow OCF − CapEx | $4.87B | $3.16B | $7.84B | $5.94B |
Shares Outstanding | 443.69M | 443.92M | 443.24M | 443.52M |